FLG rs61816760: Understanding the 2282del4 Skin Barrier Variant
The rs61816760 variant, commonly known as 2282del4, is a loss-of-function mutation in the FLG gene that disrupts the production of the filaggrin protein. This genetic change is significantly associated with an increased risk of developing atopic dermatitis, dry skin, and related allergic conditions.
What each genotype means
Typical skin barrier function
You carry two intact copies of the filaggrin gene at this position and do not carry the 2282del4 null mutation. In population studies, this standard genotype is associated with normal filaggrin protein production and baseline risk for epidermal barrier breakdown. It does not confer an elevated genetic risk for atopic dermatitis or associated allergic conditions linked to this specific variant.
Found in approximately 96% to 98% of individuals of Northern European descent and over 99% of non-European populations.
Increased eczema risk
You carry one copy of the 2282del4 frameshift loss-of-function allele, which causes premature termination of profilaggrin translation and reduces overall filaggrin levels in the epidermis. Research shows that heterozygous carriers have a significantly higher statistical risk for developing atopic dermatitis (eczema), dry skin, and secondary allergic sensitizations along the atopic march. However, not all carriers develop clinical symptoms, as environmental triggers and other genetic factors also influence skin barrier integrity.
Carried by approximately 2% to 4% of individuals of Northern European ancestry; it is extremely rare or virtually absent in East Asian and African populations.
Substantially impaired skin barrier
You carry two copies of the 2282del4 null allele, leading to a marked absence of normal filaggrin protein in the stratum corneum. In clinical studies, homozygous or compound heterozygous filaggrin null genotypes are strongly linked to ichthyosis vulgaris and severe, early-onset atopic dermatitis that often persists into adulthood. These statistical findings highlight compromised barrier integrity, though management strategies can help support cutaneous hydration.
Extremely rare across all populations, occurring in fewer than 1 in 1,000 individuals of European descent.
What is the rs61816760 Variant?
The rs61816760 variant is a specific genetic alteration located within the FLG gene, which provides instructions for creating the filaggrin protein. In scientific literature, this variant is frequently referred to as 2282del4, indicating a deletion of four DNA base pairs at a specific position. This deletion causes a frameshift in the genetic code, which typically leads to the production of a truncated, non-functional protein. Because the body cannot produce enough functional filaggrin, the structural integrity of the outermost layer of the skin, known as the stratum corneum, is compromised. This variant is one of several well-characterized null mutations in the FLG gene that have been extensively studied for their impact on skin health and barrier function.
The Role of the FLG Gene
The FLG gene is essential for maintaining a healthy skin barrier. It encodes profilaggrin, a large precursor protein that is processed into filaggrin within the skin cells called keratinocytes. Filaggrin acts as a molecular glue, helping to aggregate keratin filaments and compact the cells of the epidermis. This process is vital for creating a strong, protective barrier that keeps moisture in and prevents environmental allergens, irritants, and pathogens from penetrating the skin. When the FLG gene is mutated, as seen with rs61816760, the resulting deficiency in filaggrin can lead to a thinner, more permeable skin barrier. This structural weakness is a primary factor in the development of conditions like ichthyosis vulgaris, a disorder characterized by dry, scaly skin, and is a major contributor to the susceptibility of atopic dermatitis.
Research and Clinical Associations
Research has consistently identified rs61816760 as a strong predisposing factor for atopic dermatitis, commonly known as eczema. Studies show that individuals carrying this variant are more likely to experience early-onset eczema that may persist into adulthood. Beyond skin inflammation, the variant is also associated with an increased risk of allergic sensitization, asthma, and chronic irritant contact dermatitis. The evidence for these associations is robust, with numerous cohort studies demonstrating high statistical significance. However, it is important to note that carrying this variant does not guarantee the development of these conditions. Many people with the mutation may have mild or no symptoms, while others without the mutation may still develop eczema due to a complex interplay of other genetic, environmental, and immunological factors. The clinical impact is considered a significant risk factor rather than a direct cause.
Population Frequency
The rs61816760 variant is most prevalent in populations of European ancestry. Studies estimate that the carrier frequency for common FLG null mutations, including 2282del4, is approximately 2% to 4% in these populations. Because these mutations are relatively common, they are considered a major genetic contributor to skin barrier dysfunction in these groups. Frequency data can vary significantly between different ethnic and geographic populations, and research continues to map the distribution of these variants globally. Understanding these frequencies helps researchers better grasp the prevalence of atopic conditions across different demographics.
Managing Your Genetic Information
Knowing your status for the rs61816760 variant can provide insight into your predisposition for skin barrier issues, but it should not be used for self-diagnosis. If you are concerned about skin conditions, allergies, or asthma, the most effective approach is to consult with a dermatologist or an allergist. These professionals can evaluate your symptoms, medical history, and environmental triggers to provide personalized care. There is no 'cure' for a genetic variant, but many effective strategies exist to manage skin health, such as the use of emollients to support the skin barrier and avoiding known irritants. Always discuss any concerns about your health or potential treatments with a qualified healthcare provider rather than relying solely on genetic test results.
How common is this variant?
The rs61816760 variant is found in approximately 2-4% of individuals of Northern European descent.
Frequently asked questions
Does having the rs61816760 variant mean I will get eczema?
No, having this variant does not guarantee you will develop eczema. It is a risk factor that increases susceptibility, but environmental factors and other genes also play a significant role in whether the condition develops.
Can I fix my FLG gene mutation?
Currently, there is no medical treatment to correct a genetic mutation in the FLG gene. Management focuses on supporting the skin barrier through proper hydration and avoiding triggers that cause inflammation.
Is rs61816760 the same as 2282del4?
Yes, rs61816760 is the unique identifier (rsID) used in scientific databases for the specific genetic change known as 2282del4 in the FLG gene.
Should I get tested for this variant?
Genetic testing for this variant is generally not required for routine medical care. If you have persistent skin issues, it is best to see a dermatologist who can diagnose and treat your symptoms regardless of your genetic status.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs61816760?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FLG
Loss-of-function variant (p.Lys501Ter) in FLG, a major predisposing factor for atopic dermatitis and ichthyosis vulgaris.
Filaggrin missense and splice-region variant associated with skin barrier disruption, atopic dermatitis, and allergic sensitization.
Loss-of-function mutation 2282del4 in filaggrin predisposing to peanut allergy.
Filaggrin coding variant associated with skin barrier disruption and allergic conditions.
A filaggrin locus variant associated with impaired epidermal barrier function, predisposing to atopic dermatitis and allergic sensitization.
Skin barrier filaggrin risk-associated variant commonly implicated in the atopic march from severe infant atopic dermatitis to secondary food sensitization.